To: Profiteer who wrote (5286 ) 8/2/2000 10:09:07 PM From: chirodoc Read Replies (1) | Respond to of 6039 8/3***********FOR NEW AND WORRIED INVESTORS************ COII IS NOW UNDER HEAVY ATTACK BY THE SHORTS, THEY CAN SMELL BLOOD. IF COII GETS BACK ON NASDAQ, THIS WILL BE SEEN AS A HUGE BUYING OPPORTUNITY. IF COII DOES NOT GET NASDAQ, IT COULD TAKE 6 MONTHS TO GET BACK TO DOUBLE DIGITS. COII HAS A LOT OF CASH AND WILL BE ABLE TO CONTINUE THEIR PROCESS WITH THE FDA, THIS HIT TO THE PRICE WILL NOT AFFECT OPERATIONS. IF CTI GETS NASDAQ APPROVAL, THEN THE PRICE WILL RISE, EVEN WITH THE SHORT ATTACK. IF THEY DO NOT GET NASDAQ LISTED IT COULD TAKE A COUPLE MONTHS TO GET ON TO THE AMEX. I THINK THAT OVER THE NEXT FEW DAYS WE WILL SEE A BOTTOM FORM. JUST MHO. GOOD LUCK TO ALL, curtis MY GUESS ABOUT THE PIPELINE: coii will be nasdaq approved VERY SOON module 3 should be approved VERY SOON 4 is being prepared right now--going in to fda in august would not surprise me. module 5 should not be far behind it--my guess is september or october. we should be approved by the FDA by november these are just my guesses--i could be right or wrong, of course. --------------------------------------------------------- COII (CTI) is the leader in the emerging field of thermal medical imaging. They will be first to market with a computerized thermal imaging system to be used inititally as an adjunct to mammography. They have at least a one year head start on all competitors. Orders from foreign countries are already being taken(we assume)and they have plenty of funding for a fast and furious national roll-out. CTI will help stop the breast cancer epidemic. Then, they will become major players in the diagnosis of back/neck pain(work injuries), followed by many other potential areas such as dermatology, cardioloigy, etc. Their breast cancer detection system should be approved by summer/fall 2000. Use these links to help you in your study of COII. 1. Go to the Silicon Investor "research" thread and read the last 5-15 posts, at least. Subject 21613 2. Go to the company website and study it--especially the thermal images of cancer vs. normal tissue..see news release from Feb. for images: cti-net.com 3. Go to the yahoo COII "profile" biz.yahoo.com 4. Institutional buying interest has started. insidertrader.com 5. CTI may eventually replace mammography as the screening of choice for breast cancer--then it could be back/neck pain, melanoma, etc. CTI's EARNING POTENTIAL Let's assume that 1-2 years after approval: 300 imaging centers X 200,000-400,000 net/system = 60M net note: this is conservative. it is possible they could make FAR more per system. think about it: they can process 4-6 ladies per hour. each breast will NET around $30, with most women having both done for total of $60 per exam. $50 x 4/hour x 8 hr. day x 6 days/week x 50 weeks/yr. = NET of 480,000 per year. Then assume they sell sell 200 systems x 250,000 net = 50M NET ONE YEAR AFTER APPROVAL = $110M ASSUME 110M SHARES OUTSTANDING GIVES US $1/SHARE So if we assume that they have a p/e of 50 during the first couple years (this would drop to 25 after 1-2 years) it would give a stock price of: $50 with a 50 p/e or $25 with a 25 p/e My one year price projection after approval is $25-$50 My 2-3 year projection is $50-$100 My 5+ year prjection is $100-$200 These are all back of the envelope estimates and have no guidance from the company. I will update these estimates as time progresses. If anyone has any suggestions, please let me know. Please realize that all of these computations are very conservative. CTI will have a great run for at least 2-3 years. The long term investor wins with CTI. note: the above are only my estimates and could be right or wrong. curtis